Antimicrobial Compositions for Treating Clostridium Infections

Technology #33842

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Image Gallery
Categories
Researchers
William Self, Ph.D.
Managed By
Brion Berman
Assistant Director 407.882.0342
Patent Protection
US Patent 10,314,813

New methods using puupehenone compounds may kill or prevent Clostridium difficile infections.

A UCF researcher has developed new methods for using puupehenone compounds to possibly treat illnesses caused by Clostridium bacterial strains, such as C. difficile. Puupehenone is a marine natural product excreted by some species of sponges and coral as a defense mechanism. The UCF invention may also be effective against antibiotic-resistant strains of Clostridium.

Already resistant to multiple kinds of antibiotics, C. difficile kills 30,000-40,000 people a year in the United States. The pathogen inflames the colon, causing life-threatening diarrhea. Infections typically occur after antibiotic use and affect mostly elderly patients, those at long-term care facilities and hospitals, and people with weakened immune systems.

Technical Details

The invention focuses on puupehenone’s antimicrobial properties and methods for using concentrations of puupehenone-based compounds to kill, reduce or inhibit the cell growth of Clostridium bacterial strains, such as C. difficile, C. perfingens, C. tetani and C. botulinum. It includes methods for administering a therapeutically effective amount of a puupehenone compound (or a derivative) to those with a Clostridium infection or who are at risk of developing a Clostridium infection.

Partnering Opportunity

The research team is looking for partners to further develop the technology for commercialization.

Stage of Development

Preclinical.

Benefits

  • Can be used to develop novel drugs to treat or prevent one or more symptoms of C. difficile infections and other Clostridium infections
  • May alleviate the problem of drug resistance

Applications

Drugs for treating the vegetative as well as the spore form of any Clostridium infection.